Cell Imaging Systems Market Report – Research, Industry Analysis Reports and Market Demands

Global Cell Imaging Systems Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Cell Imaging Systems Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Basic Automated Cell Imaging Systems
- 1.3.3 HCS/HCA
- 1.3.4 Automated Live-Cell Imaging Systems
- 1.3.5 Cell Imaging Plate Readers / Image-Based Cell Analysis Systems
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Cell Imaging Systems Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Pharmaceutical & Biotechnology
- 1.4.3 CROs, CDMOs & Contract Research Organizations
- 1.4.4 Academic & Research Institutes
- 1.4.5 Hospitals & Medical Centers
- 1.4.6 Cell & Gene Therapy / Regenerative Medicine Companies
- 1.4.7 Other
1.5 Global Cell Imaging Systems Market Size & Forecast
- 1.5.1 Global Cell Imaging Systems Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Cell Imaging Systems Sales Quantity (2021-2032)
- 1.5.3 Global Cell Imaging Systems Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Cell Imaging Systems by Manufacturer

3.1 Global Cell Imaging Systems Sales Quantity by Manufacturer (2021-2026)
3.2 Global Cell Imaging Systems Revenue by Manufacturer (2021-2026)
3.3 Global Cell Imaging Systems Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Cell Imaging Systems by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Cell Imaging Systems Manufacturer Market Share in 2025
- 3.4.3 Top 6 Cell Imaging Systems Manufacturer Market Share in 2025
3.5 Cell Imaging Systems Market: Overall Company Footprint Analysis
- 3.5.1 Cell Imaging Systems Market: Region Footprint
- 3.5.2 Cell Imaging Systems Market: Company Product Type Footprint
- 3.5.3 Cell Imaging Systems Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Cell Imaging Systems Market Size by Region
- 4.1.1 Global Cell Imaging Systems Sales Quantity by Region (2021-2032)
- 4.1.2 Global Cell Imaging Systems Consumption Value by Region (2021-2032)
- 4.1.3 Global Cell Imaging Systems Average Price by Region (2021-2032)
4.2 North America Cell Imaging Systems Consumption Value (2021-2032)
4.3 Europe Cell Imaging Systems Consumption Value (2021-2032)
4.4 Asia-Pacific Cell Imaging Systems Consumption Value (2021-2032)
4.5 South America Cell Imaging Systems Consumption Value (2021-2032)
4.6 Middle East & Africa Cell Imaging Systems Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Cell Imaging Systems Sales Quantity by Type (2021-2032)
5.2 Global Cell Imaging Systems Consumption Value by Type (2021-2032)
5.3 Global Cell Imaging Systems Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Cell Imaging Systems Sales Quantity by Application (2021-2032)
6.2 Global Cell Imaging Systems Consumption Value by Application (2021-2032)
6.3 Global Cell Imaging Systems Average Price by Application (2021-2032)

7 North America

7.1 North America Cell Imaging Systems Sales Quantity by Type (2021-2032)
7.2 North America Cell Imaging Systems Sales Quantity by Application (2021-2032)
7.3 North America Cell Imaging Systems Market Size by Country
- 7.3.1 North America Cell Imaging Systems Sales Quantity by Country (2021-2032)
- 7.3.2 North America Cell Imaging Systems Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Cell Imaging Systems Sales Quantity by Type (2021-2032)
8.2 Europe Cell Imaging Systems Sales Quantity by Application (2021-2032)
8.3 Europe Cell Imaging Systems Market Size by Country
- 8.3.1 Europe Cell Imaging Systems Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Cell Imaging Systems Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Cell Imaging Systems Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Cell Imaging Systems Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Cell Imaging Systems Market Size by Region
- 9.3.1 Asia-Pacific Cell Imaging Systems Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Cell Imaging Systems Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Cell Imaging Systems Sales Quantity by Type (2021-2032)
10.2 South America Cell Imaging Systems Sales Quantity by Application (2021-2032)
10.3 South America Cell Imaging Systems Market Size by Country
- 10.3.1 South America Cell Imaging Systems Sales Quantity by Country (2021-2032)
- 10.3.2 South America Cell Imaging Systems Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Cell Imaging Systems Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Cell Imaging Systems Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Cell Imaging Systems Market Size by Country
- 11.3.1 Middle East & Africa Cell Imaging Systems Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Cell Imaging Systems Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Cell Imaging Systems Market Drivers
12.2 Cell Imaging Systems Market Restraints
12.3 Cell Imaging Systems Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Cell Imaging Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cell Imaging Systems
13.3 Cell Imaging Systems Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Cell Imaging Systems Typical Distributors
14.3 Cell Imaging Systems Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Cell Imaging Systems market size was valued at US$ 431 million in 2025 and is forecast to a readjusted size of US$ 568 million by 2032 with a CAGR of 4.1% during review period.
Cell imaging systems primarily facilitate automated imaging, integrating high-content image data with other experimental data to provide quantifiable, actionable biological insights. Consumables such as imaging reagents, wash buffers, and anti-fade agents help ensure stable and reliable fluorescence signals, while the maintenance of physiological conditions—such as temperature, pH, and oxygen concentration—relies on integrated environmental control modules to preserve cell viability during imaging. These systems enable dynamic single-cell tracking, phenotypic change analysis, and quantitative imaging of label-free live cells, as well as the automated measurement and analysis of wound healing assays.
This article covers high-content cell imaging and analysis systems (HCS/HCA).
The growth of the cell imaging systems market is not simply driven by the replacement or upgrade of conventional microscopy equipment. More fundamentally, it reflects the transition of cell-based experiments from manual observation and endpoint measurement toward automation, continuous monitoring, and quantitative analysis. In the past, cell imaging was mainly used for experimental documentation and morphological observation, with product value concentrated in optical imaging quality. However, in current drug discovery, cell therapy, organoid research, and high-content screening workflows, users increasingly care about whether the system can generate reproducible, quantifiable, and traceable cellular data with less manual intervention. As a result, automated cell imaging systems are evolving from standalone instruments into integrated cell experimentation platforms, and competition is shifting from hardware specifications to imaging algorithms, workflow compatibility, data management, and application-specific solutions.
On the demand side, pharmaceutical companies and CROs are key drivers of high-end automated cell imaging systems. Rising demand for phenotypic screening, cytotoxicity assessment, immune-cell killing assays, and 3D cell model evaluation in drug discovery has made high-content imaging and multiparametric analysis increasingly important. At the same time, academic research institutes, hospital-based translational research platforms, and cell therapy companies place greater emphasis on long-term live-cell monitoring, low-disturbance imaging, and cell-state evaluation. This is pushing the market toward real-time, dynamic, label-free, and 3D-model-compatible imaging capabilities.
From a competitive landscape perspective, the market has formed a structure in which high-content imaging platform vendors, live-cell dynamic imaging specialists, and general automated cell imaging suppliers compete in parallel. Molecular Devices under Danaher, with its ImageXpress series, Revvity with its Opera / Operetta series, and Yokogawa with its CellVoyager series have strong influence in high-content imaging and drug screening applications, with products emphasizing high throughput, multiparametric analysis, and complex cell model processing. Sartorius with Incucyte, Axion BioSystems with Omni, CYTENA with CELLCYTE, and Curiosis with Celloger are more focused on long-term live-cell dynamic monitoring and have strong recognition in cell proliferation, migration, toxicity, immune-cell killing, and cell culture monitoring applications. Thermo Fisher’s EVOS, Agilent BioTek’s Cytation / Lionheart, ZEISS, and Nikon cover broader automated cell imaging and research laboratory use cases. Overall, industry competition is no longer limited to the performance comparison of individual instruments, but is increasingly centered on product portfolio depth, application coverage, software-based analytical capabilities, and integration into customers’ experimental workflows.
This report is a detailed and comprehensive analysis for global Cell Imaging Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell Imaging Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Cell Imaging Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Cell Imaging Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Cell Imaging Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell Imaging Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell Imaging Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Thermo Fisher Scientific, Agilent, Revvity, Sartorius AG, ZEISS, Yokogawa Electric, Nanolive, Axion BioSystems, CYTENA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cell Imaging Systems market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Basic Automated Cell Imaging Systems
HCS/HCA
Automated Live-Cell Imaging Systems
Cell Imaging Plate Readers / Image-Based Cell Analysis Systems
Market segment by Application
Pharmaceutical & Biotechnology
CROs, CDMOs & Contract Research Organizations
Academic & Research Institutes
Hospitals & Medical Centers
Cell & Gene Therapy / Regenerative Medicine Companies
Other
Major players covered
Danaher
Thermo Fisher Scientific
Agilent
Revvity
Sartorius AG
ZEISS
Yokogawa Electric
Nanolive
Axion BioSystems
CYTENA
Curiosis
NanoEnTek
Blue-Ray Biotech
Etaluma
World Precision Instruments
PHI / Altium
Live Cell Instrument
Tecan
Nikon
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cell Imaging Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cell Imaging Systems, with price, sales quantity, revenue, and global market share of Cell Imaging Systems from 2021 to 2026.
Chapter 3, the Cell Imaging Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cell Imaging Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cell Imaging Systems market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cell Imaging Systems.
Chapter 14 and 15, to describe Cell Imaging Systems sales channel, distributors, customers, research findings and conclusion.

Buy now